Optogenetic Stimulation of Dynorphinergic Neurons Within the Dorsal Raphe Activate Kappa Opioid Receptors in the Ventral Tegmental Area and Ablation of Dorsal Raphe Prodynorphin or Kappa Receptors in Dopamine Neurons Blocks Stress Potentiation Of...

Overview

Journal Addict Neurosci

Date 2022 Sep 30

PMID 36176476

Authors

Antony D Abraham

Sanne M Casello

Benjamin B Land

Charles Chavkin

Affiliations

Soon will be listed here.

Abstract

Behavioral stress exposure increases the risk of drug-taking in individuals with substance use disorders by mechanisms involving the dynorphins, which are the endogenous neuropeptides for the kappa opioid receptor (KOR). KOR agonists have been shown to encode dysphoria, aversion, and changes in reward valuation, and kappa opioid antagonists are in clinical development for treating substance use disorders. In this study, we confirmed that KORs were expressed in dopaminergic neurons in the ventral tegmental area (VTA) of male C57BL6/J mice. Genetic ablation of KORs from dopamine neurons blocked the potentiating effects of repeated forced swim stress on cocaine conditioned place preference (CPP). KOR activation inhibited dopamine neuron GCaMP6m calcium activity in VTA during swim stress and caused a rebound enhancement during the period after stress exposure. Transient optogenetic inhibition of VTA dopamine neurons with AAV5-DIO-SwiChR was acutely aversive in a real time place preference assay and blunted cocaine CPP when inhibition was administered concurrently with cocaine conditioning. However, when inhibition preceded cocaine conditioning by 30 min, cocaine CPP was enhanced. Retrograde tracing with CAV2-DIO-ZsGreen identified a population of prodynorphin neurons in the dorsal raphe nucleus (DRN) projecting to the VTA. Optogenetic stimulation of dynorphinergic neurons within the DRN by Channelrhodopsin2 activated KOR in VTA and ablation of prodynorphin blocked stress potentiation of cocaine CPP. Together, these studies demonstrate the presence of a dynorphin/KOR midbrain circuit that projects from the DRN to VTA and is involved in altering the dynamic response of dopamine neuron activity to enhance drug reward learning.

Citing Articles

G protein Inactivation as a Mechanism for Addiction Treatment.

Neiswanger C, Ruiz M, Kimball K, Lee J, Land B, Berndt A bioRxiv. 2025; .

PMID: 39763910 PMC: 11702588. DOI: 10.1101/2024.12.16.628727.

Distinct Neuromodulatory Effects of Endogenous Orexin and Dynorphin Corelease on Projection-Defined Ventral Tegmental Dopamine Neurons.

Mohammadkhani A, Qiao M, Borgland S J Neurosci. 2024; 44(39).

PMID: 39187377 PMC: 11426376. DOI: 10.1523/JNEUROSCI.0682-24.2024.

Kappa Opioid Receptors in Mesolimbic Terminals Mediate Escalation of Cocaine Consumption.

Gordon-Fennell L, Farero R, Burgeno L, Murray N, Abraham A, Soden M bioRxiv. 2024; .

PMID: 38187718 PMC: 10769440. DOI: 10.1101/2023.12.21.572842.

Genetic pathways regulating the longitudinal acquisition of cocaine self-administration in a panel of inbred and recombinant inbred mice.

Khan A, Bagley J, LaPierre N, Gonzalez-Figueroa C, Spencer T, Choudhury M Cell Rep. 2023; 42(8):112856.

PMID: 37481717 PMC: 10530068. DOI: 10.1016/j.celrep.2023.112856.

Modulation of 5-HT release by dynorphin mediates social deficits during opioid withdrawal.

Pomrenze M, Cardozo Pinto D, Neumann P, Llorach P, Tucciarone J, Morishita W Neuron. 2022; 110(24):4125-4143.e6.

PMID: 36202097 PMC: 9789200. DOI: 10.1016/j.neuron.2022.09.024.

References

Chen C, Willhouse A, Huang P, Ko N, Wang Y, Xu B . Characterization of a Knock-In Mouse Line Expressing a Fusion Protein of κ Opioid Receptor Conjugated with tdTomato: 3-Dimensional Brain Imaging via CLARITY. eNeuro. 2020; 7(4). PMC: 7385665. DOI: 10.1523/ENEURO.0028-20.2020. View

Chavkin C, Cohen J, Land B . Repeated Administration of Norbinaltorphimine Produces Cumulative Kappa Opioid Receptor Inactivation. Front Pharmacol. 2019; 10:88. PMC: 6373456. DOI: 10.3389/fphar.2019.00088. View

Rose J, Karkhanis A, Chen R, Gioia D, Lopez M, Becker H . Supersensitive Kappa Opioid Receptors Promotes Ethanol Withdrawal-Related Behaviors and Reduce Dopamine Signaling in the Nucleus Accumbens. Int J Neuropsychopharmacol. 2015; 19(5). PMC: 4886667. DOI: 10.1093/ijnp/pyv127. View

Polter A, Kauer J . Stress and VTA synapses: implications for addiction and depression. Eur J Neurosci. 2014; 39(7):1179-88. PMC: 4019343. DOI: 10.1111/ejn.12490. View

Siciliano C, Calipari E, Cuzon Carlson V, Helms C, Lovinger D, Grant K . Voluntary ethanol intake predicts κ-opioid receptor supersensitivity and regionally distinct dopaminergic adaptations in macaques. J Neurosci. 2015; 35(15):5959-68. PMC: 4397597. DOI: 10.1523/JNEUROSCI.4820-14.2015. View

Huang K, Ochandarena N, Philson A, Hyun M, Birnbaum J, Cicconet M . Molecular and anatomical organization of the dorsal raphe nucleus. Elife. 2019; 8. PMC: 6726424. DOI: 10.7554/eLife.46464. View

Edwards N, Tejeda H, Pignatelli M, Zhang S, McDevitt R, Wu J . Circuit specificity in the inhibitory architecture of the VTA regulates cocaine-induced behavior. Nat Neurosci. 2017; 20(3):438-448. DOI: 10.1038/nn.4482. View

Koob G, Kreek M . Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry. 2007; 164(8):1149-59. PMC: 2837343. DOI: 10.1176/appi.ajp.2007.05030503. View

Margolis E, Karkhanis A . Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion. Neurochem Int. 2019; 129:104504. PMC: 6702044. DOI: 10.1016/j.neuint.2019.104504. View

10.

Margolis E, Lock H, Chefer V, Shippenberg T, Hjelmstad G, Fields H . Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. Proc Natl Acad Sci U S A. 2006; 103(8):2938-42. PMC: 1413839. DOI: 10.1073/pnas.0511159103. View

11.

Margolis E, Hjelmstad G, Bonci A, Fields H . Both kappa and mu opioid agonists inhibit glutamatergic input to ventral tegmental area neurons. J Neurophysiol. 2004; 93(6):3086-93. DOI: 10.1152/jn.00855.2004. View

12.

Lemos J, Roth C, Messinger D, Gill H, Phillips P, Chavkin C . Repeated stress dysregulates κ-opioid receptor signaling in the dorsal raphe through a p38α MAPK-dependent mechanism. J Neurosci. 2012; 32(36):12325-36. PMC: 3477582. DOI: 10.1523/JNEUROSCI.2053-12.2012. View

13.

Kim H, Ahrlund-Richter S, Wang X, Deisseroth K, Carlen M . Prefrontal Parvalbumin Neurons in Control of Attention. Cell. 2016; 164(1-2):208-218. PMC: 4715187. DOI: 10.1016/j.cell.2015.11.038. View

14.

Volkow N, Fowler J, Wang G, Swanson J, Telang F . Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol. 2007; 64(11):1575-9. DOI: 10.1001/archneur.64.11.1575. View

15.

Meng F, Xie G, Thompson R, Mansour A, Goldstein A, Watson S . Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc Natl Acad Sci U S A. 1993; 90(21):9954-8. PMC: 47691. DOI: 10.1073/pnas.90.21.9954. View

16.

Polter A, Barcomb K, Chen R, Dingess P, Graziane N, Brown T . Constitutive activation of kappa opioid receptors at ventral tegmental area inhibitory synapses following acute stress. Elife. 2017; 6. PMC: 5389861. DOI: 10.7554/eLife.23785. View

17.

Berndt A, Lee S, Ramakrishnan C, Deisseroth K . Structure-guided transformation of channelrhodopsin into a light-activated chloride channel. Science. 2014; 344(6182):420-4. PMC: 4096039. DOI: 10.1126/science.1252367. View

18.

Sinha R . Chronic stress, drug use, and vulnerability to addiction. Ann N Y Acad Sci. 2008; 1141:105-30. PMC: 2732004. DOI: 10.1196/annals.1441.030. View

19.

Thomas C, Mohammadkhani A, Rana M, Qiao M, Baimel C, Borgland S . Optogenetic stimulation of lateral hypothalamic orexin/dynorphin inputs in the ventral tegmental area potentiates mesolimbic dopamine neurotransmission and promotes reward-seeking behaviours. Neuropsychopharmacology. 2021; 47(3):728-740. PMC: 8782948. DOI: 10.1038/s41386-021-01196-y. View

20.

Evans R, Twedell E, Zhu M, Ascencio J, Zhang R, Khaliq Z . Functional Dissection of Basal Ganglia Inhibitory Inputs onto Substantia Nigra Dopaminergic Neurons. Cell Rep. 2020; 32(11):108156. PMC: 9887718. DOI: 10.1016/j.celrep.2020.108156. View